CN101919965A - Drug for treating hyperlipidaemia - Google Patents
Drug for treating hyperlipidaemia Download PDFInfo
- Publication number
- CN101919965A CN101919965A CN2009100323153A CN200910032315A CN101919965A CN 101919965 A CN101919965 A CN 101919965A CN 2009100323153 A CN2009100323153 A CN 2009100323153A CN 200910032315 A CN200910032315 A CN 200910032315A CN 101919965 A CN101919965 A CN 101919965A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- medicine
- drug
- shujun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a drug for treating hyperlipidaemia, which is prepared from rhizoma alismatis, rhizoma polygonati, rhizoma atractylodis, semen cassiae and prepared rhubarb. The invention has reasonable formula and favorable treating effect, and the effective rate is more than 88%.
Description
Technical field:
The present invention relates to a kind of Chinese medicine.
Background technology:
The medicine of existing treatment hyperlipemia is generally Western medicine, can not radical curing of disease, easily recurrence.
Summary of the invention:
The object of the present invention is to provide a kind of compatibility reasonable, the medicine of the treatment hyperlipemia that therapeutic effect is good.
Technical solution of the present invention is:
A kind of medicine for the treatment of hyperlipemia is characterized in that: the raw material by following weight portion is made:
20～30 parts of Rhizoma Alismatis
10～20 parts of Rhizoma Polygonatis
10～20 parts of Rhizoma Atractylodis
10～20 parts of Semen Cassiaes
3～5 parts of SHUJUN.
The medicine of described treatment hyperlipemia, make by the raw material of following weight portion:
22 parts of Rhizoma Alismatis
18 parts of Rhizoma Polygonatis
15 parts of Rhizoma Atractylodis
12 parts of Semen Cassiaes
3 parts of SHUJUN.
The medicine of described treatment hyperlipemia, make by the raw material of following weight portion:
25 parts of Rhizoma Alismatis
11 parts of Rhizoma Polygonatis
14 parts of Rhizoma Atractylodis
17 parts of Semen Cassiaes
5 parts of SHUJUN.
The present invention fills a prescription rationally, and therapeutic effect is good, and effective percentage reaches more than 88%.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
A kind of medicine for the treatment of hyperlipemia, make by the raw material of following weight portion:
22 parts of Rhizoma Alismatis
18 parts of Rhizoma Polygonatis
15 parts of Rhizoma Atractylodis
12 parts of Semen Cassiaes
3 parts of SHUJUN.
Embodiment 2:
A kind of medicine for the treatment of hyperlipemia, make by the raw material of following weight portion:
25 parts of Rhizoma Alismatis
11 parts of Rhizoma Polygonatis
14 parts of Rhizoma Atractylodis
17 parts of Semen Cassiaes
5 parts of SHUJUN.
Claims (3)
1. medicine for the treatment of hyperlipemia, it is characterized in that: the raw material by following weight portion is made:
20～30 parts of Rhizoma Alismatis
10～20 parts of Rhizoma Polygonatis
10～20 parts of Rhizoma Atractylodis
10～20 parts of Semen Cassiaes
3～5 parts of SHUJUN.
2. the medicine of treatment hyperlipemia according to claim 1 is characterized in that: the raw material by following weight portion is made:
22 parts of Rhizoma Alismatis
18 parts of Rhizoma Polygonatis
15 parts of Rhizoma Atractylodis
12 parts of Semen Cassiaes
3 parts of SHUJUN.
3. the medicine of treatment hyperlipemia according to claim 1 is characterized in that: the raw material by following weight portion is made:
25 parts of Rhizoma Alismatis
11 parts of Rhizoma Polygonatis
14 parts of Rhizoma Atractylodis
17 parts of Semen Cassiaes
5 parts of SHUJUN.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100323153A CN101919965A (en) | 2009-06-10 | 2009-06-10 | Drug for treating hyperlipidaemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100323153A CN101919965A (en) | 2009-06-10 | 2009-06-10 | Drug for treating hyperlipidaemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101919965A true CN101919965A (en) | 2010-12-22 |
Family
ID=43335349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100323153A Pending CN101919965A (en) | 2009-06-10 | 2009-06-10 | Drug for treating hyperlipidaemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101919965A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742829A (en) * | 2011-04-18 | 2012-10-24 | 北京天植百桂生物技术有限公司 | Dietetic therapy product for regulating blood fat and preparation method thereof |
-
2009
- 2009-06-10 CN CN2009100323153A patent/CN101919965A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742829A (en) * | 2011-04-18 | 2012-10-24 | 北京天植百桂生物技术有限公司 | Dietetic therapy product for regulating blood fat and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101721600A (en) | Medicine for treating neurasthenia | |
| CN102266475A (en) | Chinese medicinal composition for treating insomnia | |
| CN102370954A (en) | Medicine for treating chronic rhinitis | |
| CN101919965A (en) | Drug for treating hyperlipidaemia | |
| CN102309602A (en) | Traditional Chinese medicine (TCM) prescription for treating urticaria | |
| CN101919915A (en) | Drug for treating gastroptosis | |
| CN103083588A (en) | Medicine for losing weight | |
| CN102018818A (en) | Medicine for treating myasthenia gravis | |
| CN101721581A (en) | Medicine for treating ascarid of biliary tract | |
| CN101919958A (en) | Medicine for treating neurasthenia | |
| CN102370844A (en) | Medicine for treating lumbar pain due to internal injury caused by overstrain | |
| CN102462793A (en) | Medicine for treating infantile diarrhea | |
| CN102370785A (en) | Medicine for treating oral ulcer | |
| CN101919893A (en) | Drug for treating arthritis | |
| CN101919912A (en) | Drug for treating cerebral thrombosis | |
| CN101919945A (en) | Medicine for treating obesity | |
| CN102370873A (en) | Medicament for treating chronic pharyngitis | |
| CN101773639A (en) | Drug for treatment of Parkinson disease | |
| CN101919916A (en) | Medicine for treating low blood pressure | |
| CN102370717A (en) | Medicine for treating conjunctivitis | |
| CN101721650A (en) | Medicine for treating infantile diarrhea | |
| CN102370880A (en) | Drug for treating lumbago caused by arthromyodynia | |
| CN101919932A (en) | Medicine for treating urethritis | |
| CN101919929A (en) | Drug for treating anemia | |
| CN101919921A (en) | Medicament for curing urinary system infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20101222 |